Boldenone Undecylenate (Equipoise)

Research records

Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.

Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.

Boldenone Undecylenate (Equipoise)

An anabolic steroid developed for veterinary use that was never FDA-approved for human medicine.

Evidence category: Preclinical. This describes the source category, not approval or certainty.

Regulatory statement in source: Never approved for human use (veterinary only).

Boldenone undecylenate (Equipoise) is a synthetic anabolic steroid originally developed for veterinary use, primarily in horses. It was marketed as Parenabol for human use in the 1950s-1970s but was discontinued and never received modern FDA approval. It is not approved for any human medical condition.

Benefits reported in the imported source

Risks and limits

• Not approved for human use; safety and efficacy in humans not established under modern standards
• Schedule III controlled substance in the United States
• No current medical indication

Source bottom line: Never approved for human medical use despite historical veterinary application; classified as a controlled substance.

Uncertainty: Reference information only. Not medical advice.

Study protocols — reports, not instructions

No study protocol recorded in this snapshot. This does not establish that no study exists.

Community and practice descriptions

Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.

No community description recorded. This entry has no final B-82 outcome record; it is not a researched-empty finding.

Pharmacokinetic context

Historical half-life estimate: 336 hours. Westreich, in Ruiz & Strain, Lowinson and Ruiz's Substance Abuse (2011), p.358 — compiled reference, no controlled human PK trial; boldenone is primarily a veterinary compound Population/route context and estimates may differ. This is not a schedule or a verified human dosing rule.

Source references

• Boldenone Undecylenate - Wikipedia
• Boldenone - ScienceDirect Overview (availability check 2026-10-15: source not retrieved; HTTP 403)